Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
194.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 8.00 (4.211%)
Market Cap: £3.60m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

Trading Update

16 Jan 2024 07:00

RNS Number : 7648Z
Norman Broadbent PLC
16 January 2024
 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

Norman Broadbent plc

("Norman Broadbent" or the " Group")

 

Trading Update

 

Strategic turnaround delivers return to profitability and highest NFI and EBITDA in over a decade

 

Norman Broadbent (AIM: NBB), a leading Executive Search and Interim Management firm, provides the following trading update for the three months ended 31 December 2023 ("Q4 2023") and the year ended 31 December 2023 ("FY23"). The figures used in this announcement remain subject to audit.

 

Q4 2023 Highlights

· Group Net Fee Income ("NFI") up 13% to £2.6m (Q4 2021: £2.3m)

· Q4 2023 positive run rate continuing into Q1 2024 with contracted revenue up 15% to £1.5m (Q1 2023: £1.3m)

 

FY23 Highlights

· NFI up 44% to £10.5m (FY 2022: £7.3m)

· Underlying EBITDA1 of approximately £0.9m, up more than £0.8m (FY 2022: £0.1m)

· Profit before tax of approximately £0.3m, up over £0.6m (FY 2022: loss before tax £0.3m) and net cash flow positive in the year

· Early redemption and conversion of outstanding £0.4m convertible loan notes

· Net cash position improved to £0.4m2 as at 31 December 2023 from net debt of £1.1m2 as at 31 December 2022

 

1 excludes share based payment charges

2 excluding lease liabilities

 

Kevin Davidson, Group CEO of Norman Broadbent, commented:

"Our strategic plan continues to deliver and I thank the whole team for their outstanding performance. In the two years since we started this journey, and amid challenging market conditions, we have almost doubled NFI, increased profit before tax by over £0.9m, returned to meaningful profitability and become net cash flow positive. This success is attributed to the strength of our team, the quality hires we have made and our continued focus on productivity improvements across the business.

 

While the executive search and broader recruitment markets were challenging in 2023, we have bucked the trend by growing the size of our team and still delivered a strong set of financial results. In 2024, we plan to continue to invest and pursue our aggressive growth strategy, whilst remaining profitable and generating positive net cash flows. This will be organically led, leveraging the renewed attractiveness of our brand proposition while exploring synergistic acquisition opportunities as appropriate.

 

While being cognisant of the macroeconomic headwinds, the strong momentum established across the business and some easing of inflationary pressures in the economy mean that we are increasingly confident in our ability to overachieve against our previously stated target of £1.25m of EBITDA in 2025."

 

For further information please contact:

 

Norman Broadbent plc

Kevin Davidson, CEO

Mehr Malik, CFO

 

+44 (0)20 7484 0000

 

Shore Capital (Nominated Adviser and Broker)

Tom Griffiths / Tom Knibbs (Corporate Advisory)

Henry Willcocks (Corporate Broking)

 

+44 (0)20 7408 4090

Alma (Financial Communications Adviser)

Rebecca Sanders-Hewett

Kinvara Verdon

David Ison

normanbroadbent@almastrategic.com

+44 (0)20 3405 0205

 

About Norman Broadbent:

 

Norman Broadbent (AIM: NBB) is a professional services firm focused on executive search, senior interim management solutions and bespoke leadership advisory services working across the UK and internationally. ?

 

Established as the first UK-headquartered search firm in 1979, the firm has a 40+ year track record of shaping leadership across industries including Consumer, Financial Services, Industrials, Life Sciences, Investor and TMT.?

 

www.normanbroadbent.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVALDIELIS
Date   Source Headline
20th May 202610:40 amRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
8th May 20267:00 amRNSDirectorate Change
28th Apr 20265:25 pmRNSCourt Approval of Capital Reduction
22nd Apr 20267:00 amRNSPosting of Annual Report & Notice of AGM
21st Apr 20267:00 amRNSQ1 2026 Trading Update
20th Apr 20267:00 amRNSDirectorate Change
31st Mar 20269:11 amRNSTotal Voting Rights
26th Mar 20262:00 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSFinal Results
18th Mar 20268:00 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSProposed Capital Reduction
9th Mar 20269:23 amRNSReplacement- Results Notice/Investor Presentation
9th Mar 20267:00 amRNSNotice of Interim Results & Investor Presentation
25th Feb 20267:00 amRNSAcquisition And Total Voting Rights
6th Feb 20267:03 amRNSDirectorate Change
21st Jan 20267:00 amRNSDirectorate Change
15th Jan 20267:00 amRNSQ4 and FY25 Trading Update
13th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSChange of Auditor
8th Sep 20257:00 amRNSInterim Results
19th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
10th Jul 20257:00 amRNSH1 2025 Trading Update
19th Jun 20252:49 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
22nd May 202512:58 pmRNSResult of AGM, Capital Reorganisation and TVR
22nd May 20257:00 amRNSAGM Statement
22nd Apr 20257:00 amRNSPosting of ARA & Notice of AGM
2nd Apr 20257:00 amRNSQ1 2025 Trading Update and Final Results
4th Mar 20257:00 amRNSNotice of Results & Investor Presentation
16th Jan 20257:00 amRNSTrading Update
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.